These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 15580281)

  • 1. Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies?
    Gidron A; Verma A; Doyle M; Boggio L; Evens A; Gordon L; Singhal S; Tallman M; Williams S; Winter J; Mehta J
    Bone Marrow Transplant; 2005 Feb; 35(3):243-6. PubMed ID: 15580281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-volume leukapheresis in pediatric patients: pre-apheresis peripheral blood CD34+ cell count predicts progenitor cell yield.
    Díaz MA; Garcia-Sanchez F; Lillo R; Vicent MG; Vicario JL; Madero L
    Haematologica; 1999 Jan; 84(1):32-5. PubMed ID: 10091391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic progenitor cell count, but not immature platelet fraction value, predicts successful harvest of autologous peripheral blood stem cells.
    Mitani N; Yujiri T; Tanaka Y; Tanaka M; Fujii Y; Hinoda Y; Tanizawa Y
    J Clin Apher; 2011; 26(3):105-10. PubMed ID: 21647950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of CD34+ cells during leukapheresis allows a single, successful collection of hemopoietic progenitors in patients with low numbers of circulating stem cells.
    de Fabritiis P; Gonzalez M; Meloni G; De Propris MS; Bellucci R; Cordone I; Gozzer M; Leone G; Mandelli F
    Bone Marrow Transplant; 1999 Jun; 23(12):1229-36. PubMed ID: 10414908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobilization strategies for the collection of peripheral blood progenitor cells: Results from a pilot study of delayed addition G-CSF following chemotherapy and review of the literature.
    Jacoub JF; Suryadevara U; Pereyra V; Colón D; Fontelonga A; Mackintosh FR; Hall SW; Ascensão JL
    Exp Hematol; 2006 Nov; 34(11):1443-50. PubMed ID: 17046563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD34(+) cell collection efficiency does not correlate with the pre-leukapheresis hematocrit.
    Mehta J; Oyama Y; Winter J; Williams S; Tallman M; Singhal S; Villa M; Shook T; Burt R; Traynor A; Soff G; Masarik S; Ramsey G; Gordon L
    Bone Marrow Transplant; 2001 Sep; 28(6):597-601. PubMed ID: 11607773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
    Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
    Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilization.
    Fu P; Bagai RK; Meyerson H; Kane D; Fox RM; Creger RJ; Cooper BW; Gerson SL; Laughlin MJ; Koc ON; Lazarus HM
    Bone Marrow Transplant; 2006 Aug; 38(3):189-96. PubMed ID: 16850032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood stem cell collection in children with acute leukemia: effectiveness of the 'DIAVE' mobilizing regimen.
    Balduzzi A; Perseghin P; Dassi M; Bonanomi S; Rovelli A; Gaipa G; Biondi A; Uderzo C
    Bone Marrow Transplant; 2002 Oct; 30(7):413-6. PubMed ID: 12368951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target value tailored (TVT) apheresis approach for blood progenitor cell collection after high-dose chemotherapy and rh-G-CSF.
    Mitterer M; Hirber J; Gentilini I; Prinoth O; Fabris P; Emmerich B; Coser P; Straka C
    Bone Marrow Transplant; 1996 Sep; 18(3):611-7. PubMed ID: 8879626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The number of CD34(+) cells in peripheral blood as a predictor of the CD34(+) yield in patients going to autologous stem cell transplantation.
    Basquiera AL; Abichain P; Damonte JC; Ricchi B; Sturich AG; Palazzo ED; García JJ
    J Clin Apher; 2006 Jul; 21(2):92-5. PubMed ID: 16106446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of processed blood volume, leukocyte count and concentration of CD34-positive cells in peripheral blood on efficiency of stem cell apheresis].
    Matic GB; Ullrich H; Barlage S; Rothe G; Schmitz G
    Beitr Infusionsther Transfusionsmed; 1997; 34():139-43. PubMed ID: 9417337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of assessment of efficacy of leukapheresis volumes, 8 liters vs 12 liters.
    Demirer T; Dagli M; Ilhan O; Ayli M; Haznedar R; Fen T; Gunel N; Genc Y; Arat M; Ozcan M; Arslan O; Seyrek E; Dincer S; Ustun T; Ustael N; Koc H; Muftuoglu O; Akan H
    Bone Marrow Transplant; 2002 Jun; 29(11):893-7. PubMed ID: 12080353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobilization kinetics of peripheral blood progenitor cells after IAPVP-16 salvage chemotherapy plus G-CSF in lymphoproliferative disorders.
    Altés A; López R; Martino R; Martinez C; Cabezudo E; Muñoz L; Santamaría A; Perea G; Briones J; Salar A; Sureda A; Brunet S; Madoz P; Sierra J
    Bone Marrow Transplant; 2000 Jul; 26(2):127-32. PubMed ID: 10918421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-volume leukapheresis using femoral venous access for harvesting peripheral blood stem cells with the Fenwal CS 3000 Plus from normal healthy donors: predictors of CD34+ cell yield and collection efficiency.
    Sohn SK; Kim JG; Chae YS; Kim DH; Lee NY; Suh JS; Lee KB
    J Clin Apher; 2003; 18(1):10-5. PubMed ID: 12717787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma.
    Stiff P; Gingrich R; Luger S; Wyres MR; Brown RA; LeMaistre CF; Perry J; Schenkein DP; List A; Mason JR; Bensinger W; Wheeler C; Freter C; Parker WRL ; Emmanouilides C
    Bone Marrow Transplant; 2000 Sep; 26(5):471-81. PubMed ID: 11019835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ancestim (recombinant human stem cell factor, SCF) in association with filgrastim does not enhance chemotherapy and/or growth factor-induced peripheral blood progenitor cell (PBPC) mobilization in patients with a prior insufficient PBPC collection.
    da Silva MG; Pimentel P; Carvalhais A; Barbosa I; Machado A; Campilho F; Sousa SR; Miranda N; da Costa FL; Campos A; Vaz CP; Antas J; Passos-Coelho JL
    Bone Marrow Transplant; 2004 Oct; 34(8):683-91. PubMed ID: 15322567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood stem cell collection in multiple myeloma: a retrospective analysis of 6 years leukapheresis activity in 109 patients treated at the Istituto Nazionale dei Tumori of Milan.
    Coluccia P; Montefusco V; Tunesi S; Avella M; Bompadre A; Longoni P; Milanesi M; De Carli A; Ravagnani F
    J Clin Apher; 2009; 24(4):134-40. PubMed ID: 19591198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimising parameters for peripheral blood leukapheresis after r-metHuG-CSF (filgrastim) and r-metHuSCF (ancestim) in patients with multiple myeloma: a temporal analysis of CD34(+) absolute counts and subsets.
    Chin-Yee IH; Keeney M; Stewart AK; Belch A; Bence-Buckler I; Couban S; Howson-Jan K; Rubinger M; Stewart D; Sutherland R; Paragamian V; Bhatia M; Foley R
    Bone Marrow Transplant; 2002 Dec; 30(12):851-60. PubMed ID: 12476276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cobe Spectra is superior to Fenwal CS 3000 Plus for collection of hematopoietic stem cells.
    Mehta J; Singhal S; Gordon L; Tallman M; Williams S; Luyun R; Ali MY; Oyama Y; Villa M; Shook T; Winter J
    Bone Marrow Transplant; 2002 Apr; 29(7):563-7. PubMed ID: 11979304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.